Treatment of systemic lupus erythematosus by immunoadsorption in a patient suffering from tuberculosis

被引:23
作者
Schmaldienst, S
Jansen, M
Hollenstein, U
Graninger, W
Regele, H
Hörl, WH
Derfler, K
机构
[1] Univ Vienna, Dept Med 3, Div Nephrol & Dialysis, A-1090 Vienna, Austria
[2] Univ Vienna, Dept Med 1, Div Infect Dis, A-1090 Vienna, Austria
[3] Univ Vienna, Dept Med 3, Div Rheumatol, A-1090 Vienna, Austria
[4] Univ Vienna, Dept Med 3, Div Pathol, A-1090 Vienna, Austria
关键词
systemic lupus erythematosus (SLE); lupus nephritis; immunoadsorption; immunosuppression; tuberculosis; infections;
D O I
10.1053/ajkd.2002.30564
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We report on a 40-year-old man, admitted with fever and weight loss, in whom systemic lupus erythematosus (lupus nephritis World Health Organization type IV) and concomitant acute lung tuberculosis were diagnosed. Conventional treatment of diffuse proliferative nephritis with cytotoxic drugs was thought to be too dangerous in the presence of active tuberculosis. A combination of immunoadsorption and steroids was instituted for the treatment of systemic lupus erythematosus. Antibodies against double-stranded DNA decreased, and proteinuria decreased from 10 g/24 hours to less than 1 g/24 hours. Tuberculosis was treated initially with quadruple-drug therapy, then a triple-drug protocol. Primarily enlarged lymph nodes decreased to normal size after 3 months. The combined treatment modality of steroids and immunoadsorption was effective and safe, even in this patient with active tuberculosis. (C) 2002 by the National Kidney Foundation, Inc.
引用
收藏
页码:415 / 418
页数:4
相关论文
共 20 条
[1]  
Balakrishnan C, 1998, J Assoc Physicians India, V46, P682
[2]   Immunoadsorption onto protein A induces remission in severe systemic lupus erythematosus [J].
Braun, N ;
Erley, C ;
Klein, R ;
Kötter, I ;
Saal, J ;
Risler, T .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (09) :1367-1372
[3]  
Funauchi M, 1997, J Clin Lab Immunol, V49, P47
[4]   Prospective randomized trial of two different immunoadsorbers in severe systemic lupus erythematosus [J].
Gaubitz, M ;
Seidel, M ;
Kummer, S ;
Schotte, H ;
Perniok, A ;
Domschke, W ;
Schneider, M .
JOURNAL OF AUTOIMMUNITY, 1998, 11 (05) :495-501
[5]   Mycophenolate mofetil for the treatment of systemic lupus erythematosus: an open pilot trial [J].
Gaubitz, M ;
Schorat, A ;
Schotte, H ;
Kern, P ;
Domschke, W .
LUPUS, 1999, 8 (09) :731-736
[6]   Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis - A randomized, controlled trial [J].
Gourley, MF ;
Austin, HA ;
Scott, D ;
Yarboro, CH ;
Vaughn, EM ;
Muir, J ;
Boumpas, DT ;
Klippel, JH ;
Balow, JE ;
Steinberg, AD .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (07) :549-+
[7]  
Hernández-Cruz B, 1999, CLIN EXP RHEUMATOL, V17, P289
[8]  
Jindal B, 2000, Indian J Pathol Microbiol, V43, P311
[9]   Pulmonary tuberculosis in patients with systemic lupus erythematosus [J].
Kim, HY ;
Im, JG ;
Goo, JM ;
Lee, JK ;
Song, JW ;
Kim, SK .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1999, 173 (06) :1639-1642
[10]   Intramedullary tuberculosis manifested as Brown-Sequard syndrome in a patient with systemic lupus erythematosus [J].
Kim, WU ;
Lee, SH ;
Shim, BY ;
Min, JK ;
Hong, YS ;
Park, SH ;
Cho, CS ;
Park, CK ;
Kim, HY .
LUPUS, 2000, 9 (02) :147-150